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Abstract
Three of the four family X polymerases, DNA polymerase λ, DNA polymerase µ, and TdT have
been associated with repair of double-strand DNA breaks by nonhomologous end-joining. Their
involvement in this DNA repair process requires an N-terminal BRCT domain that mediates
interaction with other protein factors required for recognition and binding of broken DNA ends. Here
we present the NMR solution structure of the BRCT domain of DNA polymerase λ, completing the
structural portrait for this family of enzymes. Analysis of the overall fold of the polymerase λ BRCT
domain reveals structural similarity to the BRCT domains of polymerase µ and TdT, yet highlights
some key sequence and structural differences that may account for important differences in the
biological activities of these enzymes and their roles in nonhomologous end-joining. Mutagenesis
studies indicate that the conserved Arg57 residue of Pol λ plays a more critical role for binding to
the XRCC4-Ligase IV complex than its structural homolog in Pol µ, Arg43. In contrast, the
hydrophobic Leu60 residue of Pol λ contributes less significantly to binding than the structurally
homologous Phe46 residue of Pol µ. A third leucine residue involved in the binding and activity of
Pol µ, is nonconservatively replaced by a glutamine in Pol λ (Gln64) and, based on binding and
activity data, is apparently unimportant for Pol λ interactions with the NHEJ complex. In conclusion,
both the structure of the Pol λ BRCT domain and its mode of interaction with the other components
of the NHEJ complex significantly differ from the two previously studied homologs, Pol µ and TdT.
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Although substantial progress has been made in the structural and biochemical characterization
of Family X polymerases β (Pol β), Pol λ, Pol µ, and terminal deoxyribonucleotidyl transferase
(TdT), our understanding of their physiological roles remains limited. Pol β and, to a certain
extent Pol λ, are involved in recognition and resolution of single-stranded DNA breaks during
base excision repair (BER) [1,2], while Pol λ, Pol µ, and TdT have been associated with
nonhomologous end-joining (NHEJ), a pathway that resolves double strand breaks (DSBs)
[3–6]. A combination of non-overlapping expression profiles and catalytic activities dictate
distinct biological roles for Pol λ, Pol µ, and TdT in NHEJ. In that order, these polymerases
possess both decreasing dependency on template [6], as well as increasingly restricted
expression patterns [7,8]. For example, while Pol λ shows a template-dependency more similar
to canonical polymerases and is widely expressed, TdT adds nucleotides preferentially in the
absence of template, and is expressed only in lymphocytes active in V(D)J recombination.
Pol λ expression thus overlaps that of both Pol µ and TdT, but Pol λ’s participation in NHEJ
has a significantly different impact on how NHEJ repairs broken chromosomes. How, then,
are the different polymerases selected in order to carry out their distinct biological roles? Family
X polymerases λ, µ, and TdT each possess an N-terminal BRCT domain [9]which has an impact
on their physiological activity. This BRCT domain allows all three polymerases to interact
with the NHEJ factors Ku, XRCC4, and Ligase IV (reviewed in [10–12]), resulting in
recruitment of the polymerases to the DNA ends. Deletion of the BRCT domain abolishes the
ability of these polymerases to participate in NHEJ in certain contexts [4–6,13].
In order to understand the roles of these Family X polymerases in NHEJ and in other DNA
repair processes, it is essential to characterize the structure of the BRCT domains and to
elucidate the critical interaction factors that determine polymerase selection by the NHEJ
complex. Solution structures of the BRCT domains of Pol µ (PDB codes 2DUN and 2HTF
[14]) and TdT (PDB code 2COE) recently have been solved by NMR spectroscopy. These
BRCT domains exhibit a high degree of sequence identity (44%) [14,15]), a result consistent
with their comparable interactions with the Ku/XRCC4-LigaseIV complex. However,
sequence comparisons between the BRCT domains show that Pol λ, exhibits the least sequence
similarity (Pol λ vs. Pol µ 23%, Pol λ vs. TdT 20%). In order to determine whether the greater
sequence variability corresponds to a more significant structural difference, or to residue
variations within a highly conserved structure, we report here the solution structure of the Pol
λ BRCT domain. This determination completes the structural portrait for the BRCT domains
present within the Family X polymerases and provides insights into understanding the
structural basis for both the similarities and variability that characterize how these polymerases
interact with the other component proteins involved in NHEJ.
Materials and Methods
Expression and Purification of the Human Pol λ BRCT Domain
The coding sequence (residues Gly34-Pro135) of human Pol λ was cloned into the pGEX-4T3
bacterial expression vector (GE Healthcare) with a TEV protease cleavage site inserted
upstream of the Pol λ coding sequence. The vector was transformed into E. coli BL21 Codon-
Plus (DE3)-RP cells. The media utilized 100 µg/ml ampicillin and 35 µg/ml chloramphenicol
for selection of the pGEX-4T3 vector and the Codon-Plus cells. The media was either LB
medium, or M9 medium supplemented with BioExpress (Cambridge Isotope Labs) at 1:100
dilution, which we term ‘M9+’. For isotopic labeling, 15NH4Cl, 13C-glucose, U-[15N]
BioExpress and U-[13C,15N] BioExpress were used in appropriate combination to produce
either [15N]- or [13C, 15N]-Pol λ BRCT domain. The Pol λ BRCT domain was purified by
batch incubation of the soluble fraction with glutathione sepharose 4B resin, then cleaved from
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the resin using TEV protease. Cleaved protein was concentrated to 10 mg/ml, and diluted to a
final salt concentration of 75 mM NaCl using 25 mM Tris pH 7.5. The protein was further
purified by affinity chromatography over a Mono Q HR 5/5 column (GE Healthcare). The Pol
λ BRCT domain did not bind the column matrix, and eluted in the flowthrough fraction with
high purity. The final buffer conditions were 25 mM Tris pH 7.5, 75 mM NaCl. The NMR
buffer also contained 10 % D2O for the deuterium lock.
15N-labeled Pol λ BRCT was used to acquire the 3D 15N-separated Nuclear Overhauser
Enhancement Spectroscopy (NOESY) [16], 15N-T1, 15N-T2, [15N, 1H]-Nuclear Overhauser
Enhancement (NOE) relaxation [17], Carr-Purcell Meiboom-Gill (CPMG) [18,19], and
Residual Dipolar Coupling (RDC) experiments [20] with and without PF1 phage (Asla
Biotech) [21]. The 13C, 15N-labeled Pol λ BRCT was used for all other experiments, including
the 3D 13C-separated NOESY [16].
Chemical Shift Assignments and Structure Calculation
The backbone resonances were assigned primarily through a combined analysis of the
Heteronuclear Single Quantum Coherence (HSQC), HNCACB [22], and CBCACONH [23]
using the RunAbout tool in NMRViewJ [24]. Aliphatic side chain assignments were made
utilizing combinations of HNHA [25], H(CCO)NH, (H)CCONH, CCH-TOCSY, HCCH-
TOCSY [26–29], and in rare cases, the NOE experiments. Aromatic side chains were assigned
using the experiments of Yamazaki et al [30]. Data from all experiments were acquired on a
Varian INOVA 500 MHz Spectrometer equipped with a cryogenically cooled probe. The only
exception was the methyl-methyl NOESY [31], which was collected on a Varian INOVA 600
MHz Spectrometer, also with a cryogenically cooled probe to maximize the resolution.
Structure calculations utilized CYANA [32] to assign the NOEs and to calculate initial
structures that were subsequently refined with XPLOR-NIH [33]. The input data to CYANA
included the 15N- and 13C-separated NOESY experiments, dihedral bond angle restraints from
TALOS [34], and the chemical shift assignments. Subsequent refinement with XPLOR-NIH
of the best CYANA structure included the RDCs as restraints. Three rounds of refinement with
XPLOR-NIH were utilized to filter a few problematic or frequently violated restraints, mostly
in loop regions that were likely over-restrained by CYANA, which attempts to assign and
calibrate all input peaks.
Activity and binding analysis of mutant proteins
N- and C-terminal hexahistidine tagged full-length Pol λ cDNA was generated by amplification
and insertion between Nde I and Xho I sites of the bacterial expression vector pET28b
(Novagen). The downstream amplification primer altered the reading frame starting at the
second last amino acid, resulting in substitution of the terminal two amino acids (Asp574 and
Trp575 to Thr and Gly, respectively) and allowing for an in frame translation of the vector-
resident C-terminal hexahistidine tag. BRCT domain mutations were introduced in the context
of this construct. Full-length constructs (wildtype and BRCT substitution mutations) were
expressed and purified on a 1 ml HisTrap Fast-Flow Nickel column as previously described
[14], and eluted in a buffer containing 25 mM Tris-HCl pH 8.0, 250 mM KCl, 10% glyercol,
7mM β-mercaptoethanol, and 350 mM imidazole. This eluent was loaded onto a 1 ml HiTrap
heparin column and bound protein was eluted by a linear gradient of increasing KCl
concentration to 770 mM. Fractions eluted from the heparin column judged by SDS-PAGE to
be >90% pure full-length Pol λ were pooled and diluted as necessary to adjust the salt to 250
mM KCl before freezing. The Ku and XRCC4-ligase IV complexes were purified from
baculovirus-infected cells as previously described [35].
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Electrophoresis mobility shift assays (EMSA) were performed using a 60-bp double-stranded
(ds) DNA substrate made by annealing 5’ phosphorylated DAR166 (5’-
CAGCTGGGAATTCCATATGAGTACTGCAGATGCACTTGCTCGATAGATCTAACA
TGAGCC-3’) to DAR167 (5’Cy3-
GTAGGGCTCATGTTAGATCTATCGAGCAAGTGCATCTGCAGTACTCATATGGAA
TTCCCAGCTGAG-3’). 10 nM of this substrate was incubated with 1 nM Ku for 5 minutes
in a buffer containing 25 mM Tris-HCl pH 7.5, 150 mM KCl, 1% (wt/vol) polyethyleneglycol
(molecular mass, greater than 8,000 kD; PEG), 1 mM DTT, 0.5 mg/mL bovine serum albumin
(BSA), and 100nM EDTA, followed by addition of 500 ng uncut plasmid DNA, 10 nM
XRCC4-ligase IV complex, and 50 nM of Pol λ followed by an additional incubation for 10
minutes on ice. Resulting DNA-protein complexes were separated by eletrophoresis on a 3.5%
polyacrylamide gel in a buffer containing 30 mM Tris-borate (pH 8.2) and 0.3 mM EDTA
(1/3X TBE), and detected using a Typhoon fluorescent imager (GE Biosciences).
The NHEJ assay employed a 300 bp substrate with the indicated end structures prepared as
previously described [6], except substrates were fluorescently labeled by synthesis in a mix of
100 µM each dNTP supplemented with 50 µM Cy5 labeled dCTP (GE biosciences). End-
joining assays were performed by incubating on ice 25 nM Ku and 5 nM DNA substrate in a
buffer containing 25 mM Tris pH 7.5, 150 mM KCl, 1 mM DTT, 20 µg/ml BSA, 3% glycerol
(v/v), 0.1 mM EDTA, 10% PEG (w/v) for 5 minutes, followed by addition of 50 nM X4-LIV,
25 nM Pol λ, and 500 ng of uncut plasmid DNA and a 10 minute incubation on ice. Reactions
were then started by addition of 25 µM of each dNTP and 5mM MgCl2 before incubation at
37 °C for 5 minutes. Samples were then de-proteinized and subject to electrophoresis on a non-
denaturing 5% polyacrylamide gel. Substrate and product species were detected using a
Typhoon fluorescent imager and quantified using ImageQuant Total Lab software (GE
biosciences).
The following mutations of Pol λ were constructed and tested using EMSA and end-joining
assays: L60A, L60F, Q64A, Q64L, R55A, and R57A. Potential structural changes due to the
various mutations were assessed with 1D NMR using approximately 50 µM protein and a
Varian 500 MHz spectrometer using the DPFGSE sequence for water suppression [36].
Crystallization trials with Pol λ BRCT domain
Unlabeled Pol λ BRCT protein was utilized in several high-throughput crystallization screens
examining over 4000 conditions. No crystals were obtained.
Results
Chemical shift assignments and secondary structure
Figure 1 shows an annotated [1H-15N]-HSQC of the Pol λ BRCT domain. The chemical shift
assignment procedure was generally facile and 90% complete, as assessed by CYANA. Most
of the missing assignments correspond to the N-terminal three residues. In addition, Thr51,
Gly52, and Arg55 in the loop preceding α-helix 1 (Figure 2, cyan) lack assignments,
presumably due to conformational exchange broadening. Several shifts were noted to be
unusual in that they are more than two standard deviations from the mean for that atom in the
BioMagResBank (BMRB) database [37]. The shift of the Arg122 Hα is 1.93 ppm. The
backbone of this residue is in a tight turn at the end of α-helix 3 and the ϕ/ψ angles are 57.9°/
40.9°. These angles are within the acceptable range for Ramachandran plots, but are uncommon
for an arginine residue; hence, the shift is outside the norm. The Hα shift of Ala46 (5.78 ppm)
is unusual for an alanine residue, but not uncommon for other residue types within a β-sheet.
This shift likely lies outside the mean for alanine because these residues are uncommon in β-
sheets. Finally, the shift of 5.46 ppm for His82 Hδ2 is unusually low. His82, buried within the
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protein core, is absolutely conserved and the Hδ2 proton probably experiences an upfield shift
do to its proximity to the face of the indole ring of Trp114 (Figure 3). In addition, we were
able to observe the typically labile Hδ1 proton of His82, which indicates a reduced exchange
rate with water protons (Figure 1). NOE interactions were observed between the His82 Hδ1
and the methyl groups of Leu44, and the Hε2 and Hζ2 protons of Trp114, confirming the buried
position of this proton. These interactions, combined with the slow exchange of Hδ1 support
the presence of an H-bond connecting His82 Nδ1 and Arg45 C'.
Analysis of the overall fold of the Pol λ BRCT domain reveals an α/β/α motif (Figure 2), similar
to the BRCT domains of Pol µ (PDB codes 2DUN and 2HTF [14]) and TdT (PDB code 2COE)
(Figure 3A). The core of the domain is made up of a central β-sheet comprised of three short
parallel β-strands, flanked by three α-helices. These secondary structural elements are arranged
in a similar topography to the other Family X BRCT domains [14]. In addition to the core 3-
stranded β-sheet, residues 71–73 (β-strand 2) and residues 95–97 (β-strand 5) have ϕ/ψ angles
that are indicative of residues found in β-strands. However, given the positions of these strands
relative to the core β-sheet, and the poor geometries for hydrogen bonding interactions, it is
likely that these strands contribute little to the hydrogen bonding network of the β-sheet. Table
1 shows a summary of structural statistics for the ensemble of Pol λ BRCT domain structures.
The experimental restraints show very few violations, and the covalent geometry is not strained.
The ensemble RMSD for the 12 lowest energy structures refined by XPLOR-NIH is 0.68 Å
over the backbone atoms of secondary structure elements.
A salt bridge that stabilizes the position of α-helix 1 in Pol µ (Glu36-Arg44) and TdT (Glu41-
Arg49) is present but reversed in Pol λ (Arg50-Glu59). As noted above, Thr51, Gly52, and
Arg55 in the loop preceding α-helix 1 in Pol λ were not structurally well-defined (Figure 2A,
cyan) and are presumably subject to substantial exchange broadening. Interestingly, this region
of the BRCT domain in Pol µ contains at least one residue (Arg43) that is important for efficient
binding of NHEJ protein partners [14]. In the Pol µ BRCT domain structure, Arg43 is
constrained by the salt bridge with Glu72. For Pol λ, the structurally corresponding residue is
conserved (Arg57), however, this arginine is not similarly constrained. The position of the
residue on loop L1, and the apparent flexibility of that loop lead to speculation as to whether
Arg57 may mediate a similar interaction with the end-joining complex.
Structural stabilization by the C-terminus of the Pol λ BRCT
Initial studies of the Pol λ BRCT domain performed using shorter constructs that were designed
based on consensus BRCT domains resulted in poor protein expression yields. We obtained
an improved yield of soluble Pol λ BRCT using a longer construct that extended to Pro135.
There are a number of hydrophobic interactions involving those C-terminal residues that would
be expected to provide significant stability to the structure. These include interactions of
Val125 and Val127 with Trp114, which are supported by NOEs between these residues.
Phe130 also interacts with Ala113 and Leu117. Additional hydrophobic contacts link Ile132
to Val85 and/or Tyr91.
In addition, residues Ser131 and Ile132 have ϕ/ψ angles typical of β-strands, and in some
structures of the calculated ensemble, make backbone hydrogen bonds indicative of a putative
fifth β-strand, running antiparallel to β-strand 4, specifically Ile132:Leu109 and
Lys111:Phe130. However, this two residue β-strand is not present in all simulations, so we
conclude that this interaction, although intermittent, does provide some stabilization for the
central ß-sheet. A similar anti-parallel β-strand composed of at least three residues (His112-
Gln113-Leu114) also exists in the structure of TdT, but is less apparent in the structures of Pol
µ, In the structure of Pol µ, however, there are several possible hydrogen bond interactions
with the edge of the fourth β-strand. This type of ‘negative design’ is common among β-sheet
proteins, and prevents the formation of insoluble aggregates in solution that may result from
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edge-on interactions with other β-sheets [38]. Hydrogen exchange data also indicate that this
region of the protein is dynamic, confirming the transient nature of β-strand 5 in Pol λ. In
summary, the combination of a transient β-strand and multiple hydrophobic interactions
provide important stabilization to the Pol λ BRCT domain. The poor expression noted for
shorter constructs likely results from decreased stability of such truncated forms.
Conservation of sequence and structure across Family X BRCT domains
As noted above, there is 44% sequence identity between the polymerase and BRCT domains
of Pol µ and TdT (Figure 3) [15]. Structures of the BRCT domains from TdT and Pol µ are
very similar (Figure 3A); the lowest energy TdT structure superimposes on the average energy-
minimized Pol µ structure with a backbone r.m.s.d. of 1.5 Å over 96 Cα atoms (see
Footnote1). The main differences include a shorter α-helix 2 in the TdT domain, which also
perturbs the position of the loop connecting α-helix 2 and β-strand 4 (L5). In the ensemble of
Pol µ structures, this loop exhibits low sequence conservation (Figure 3B) and appears more
disordered [14].
In contrast, the extent of sequence conservation is decreased when comparing Pol λ with either
Pol µ or TdT. Sequence conservation is greater within the polymerase domains (Pol λ vs. Pol
µ 30%; Pol λ vs. TdT 27%) than within the BRCT domains (Pol λ vs. Pol µ 23%; Pol λ vs.
TdT 20%). When comparing residues across all three human Family X BRCT domains, there
is very little conservation—a total of ten residues are fully conserved (12%, Figure 3B). .Of
the ten conserved residues, five (His82, Val84, Leu109, Trp114, and Leu115) are buried within
the core of the domain, and are likely important for correct folding and stability (Figure 3B).
The other five (Gly54, Arg57, Gly69, Thr81, and V125) lie on the surface of the protein and
are exposed to solvent. Studies of site-specific Pol µ mutants have demonstrated that Arg43,
which aligns structurally with Arg57 in Pol λ, is important for binding to other components of
the NHEJ complex and for subsequent end-joining by Pol µ in this complex [14]. Gly54 and
Arg57 lie on the exposed loop preceding α-helix 1 (L1), and present a surface that presumably
contributes to the binding interface. In general, there is little overall conservation of surface
residues. The structure of Pol λ is less similar to that of TdT (r.m.s.d. of 2.0 Å over 72 Cα
atoms) than to that of Pol µ (r.m.s.d. of 1.7 Å over 71 Cα atoms), which correlates with the
degree of sequence similarity.
Structural differences among Family X BRCT domains
Though the overall folds of the three Family X BRCT domains are highly conserved (Figure
3A), there are small differences in the positioning of secondary structural elements. The most
notable difference occurs in the positioning of α-helix 2 of the Pol λ BRCT domain, which
runs almost perpendicular to the direction of the core β-strands. In Pol µ and TdT, α-helix 2 is
nearly antiparallel to the direction of the core β-strands. In order to confirm the positioning
and direction of α-helix 2, the residual dipolar couplings of residues in secondary structural
elements were fit to the CYANA structures that were calculated without utilizing the RDCs.
The agreement was very good, generally showing a strong positive correlation (r > 0.6) for
calculated versus measured RDCs. Errors for residues in α-helix 2 were not greater than for
other couplings, indicating the validity of the displayed orientation. The model was
subsequently refined with XPLOR-NIH using the RDCs. Comparison of the structures before
and after refinement shows that the protein fold was only subtly altered, although the agreement
of the calculated and measured RDCs improves to greater than 0.99. The region of the Pol λ
BRCT domain containing α-helix 2 exhibits the least sequence conservation across the Family
1All superpositions of the Family X BRCT domains were preformed using the superposition algorithm in O [39] T. Jones, J. Zou, S.
Cowan and M. Kjeldgaard Acta Crystallogr. Sect. A. 47 (1991) 110–119., and were base on β-strands 1 and 3 of the lowest energy
structure from the ensemble.
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X BRCT domains (Figure 3). Therefore, it is not surprising that this particular region of the
BRCT domains would show a lower degree of structural conservation. Given that the sequence
conservation of α-helix 2 is so low across the BRCT domain superfamily as to be nearly
undetectable [9], it seems unlikely that this region of the polymerase could dock with similar
structures. α-Helix 2 probably plays a structurally protective role, covering the hydrophobic
core β-sheet.
As would be expected from regions of low sequence conservation, structural disparities are
also apparent in loop regions of the Family X BRCT domains. For example, the loop between
β-strand 1 and α-helix 1 (L1) differs significantly among the Family X BRCT domains,
primarily due to the lack of homology within the N-terminal end of α-helix 1 (Figure 4A). In
Pol λ, α-helix 1 is positioned at a slightly different angle than the corresponding helix in Pol
µ and TdT. Interestingly, there is a slight deviation from ideal α-helical geometry near the N-
terminal end of this helix. This deviation occurs at Leu60-Phe61, and is not present in Pol µ
or TdT.
The most significant structural differences among the Family X BRCT domains are located
between α-helix 2 and β-strand 4 (Figure 4B). The length, residue composition, and
conformation of this loop vary widely among Pol µ, TdT, and Pol λ. Ostensibly, some variation
of this loop region is due to the differences in the termination of α-helix 2. Though the
orientation of this helix is similar in Pol µ and TdT, α-helix 2 in Pol λ is shorter and lies nearly
perpendicular to the plane of the direction of the β-strands, creating a loop region with a vastly
different conformation. Interestingly, in Pol µ and Pol λ, this loop contains a PPG (Pol µ: Pro91-
Gly93, Pol λ: Pro104-Gly106) motif that is absent in TdT (Figure 3B). This PPG motif
generates a similar structure in Pol µ and Pol λ, but the position of the motif is laterally
displaced. For Pol µ and Pol λ, the loop bridging α-helix 2 and β-strand 4 is proline-rich; not
so in this region of TdT. The high concentration of proline residues in this region is intriguing,
given that proline-rich sequences have been found to serve as recognition motifs for protein
binding partners [40].
Role of α-helix 1 in interactions with NHEJ binding partners
Structural characterization of the Pol µ BRCT domain revealed two solvent-exposed
hydrophobic residues on α-helix 1, Phe46 and Leu50 which, along with conserved Arg43, were
postulated to be important components of the interaction surface of this domain. Further support
for this conclusion was derived from the observation that the BRCT domain of TdT has
similarly positioned hydrophobic residues on α-helix 1 (see Footnote2). These key residues in
Pol µ were mutated to alanine and found to be important both for binding with the XRCC4-
Ligase IV components of the NHEJ complex, and for functional activation [14]. Because these
amino acids are structurally conserved in the BRCT domain of TdT, we hypothesize that these
polymerases would interact with the NHEJ repair complex in similar fashions.
The situation is somewhat less clear for Pol λ, for which only two of these positions have a
homologous residue: Arg57 and Leu60 (Arg43 and Phe46 conserved in Pol µ) (Figure 3B and
5A). For Pol λ, the corresponding R57A mutant showed dramatically impaired complex
formation (Figure 5B). Meanwhile, the effect of the L60A substitution was slightly less
detrimental. Interestingly, the L60F mutant, designed to mimic Phe46 of Pol µ, exhibited
complex formation more similar to that of wildtype. This pattern differs from that seen with
Pol µ, for which the F46A mutation is significantly more perturbing than the R43A mutation
[14]. Other similarities to Pol µ that were probed for their importance in NHEJ complex
2According to published sequence alignments (e.g. Figure 3B), these residues are both conserved in TdT. However, the structure deposited
in the Protein Data Bank (PDB code 2COE) has leucine residues at both positions.
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formation were Gln64 in Pol λ, structurally homologous to Leu50 in Pol µ; and Arg55 in Pol
λ, which forms a salt bridge with Asp86 similar to the Arg43-Glu72 interaction in Pol µ (see
figure 5A). Alanine substitution mutation of Arg55 and Gln64 in Pol λ showed no disruption
of complex formation, suggesting they are unlikely to contribute significantly to the interaction.
Mutation of Q64L, which would correspond to Leu50 in Pol µ, neither enhanced nor perturbed
complex formation.
Logically, nonhomologous end-joining activity should correlate with efficient NHEJ complex
formation. Therefore, the Pol λ BRCT domain mutants were tested for their end-joining
activity. Alanine mutants of either Arg57 or Leu60 of Pol λ showed greatly diminished end-
joining activity, relative to the enzyme with the wild-type BRCT domain. Indeed, the R57A
mutation displayed the weakest end-joining activity (Figure 5C). The L60A mutant was slightly
more active. As might be expected from similar experiments using Pol µ, the L60F substitution
mutant was more efficient in both complex formation and end-joining activity than L60A
[14]. Similar to the results in NHEJ complex formation, R55A and Q64A/L displayed similar
end-joining activity to that of wildtype Pol λ. In summary, the performance of the mutants
BRCT domains in the activity assay parallels the complex formation in the binding assay.
In order to assess whether any of these mutations produced significant structural perturbations,
we acquired 1H NMR spectra of each protein for comparison. In the 1D spectrum, Leu115 is
easily identifiable (See Supplementary Figure 1) because it is strongly shifted upfield due to
interaction with Phe61 on α-helix 1, where the mutations were made. This shift should be
particularly sensitive to potential structural changes in α-helix 1. None of the mutants show
significant changes in the overall 1H spectra, or in the shift of Leu115, CD1 (Supp. Figure 1),
supporting the conclusion that these mutations did not introduce major structural changes in
the domain.
Determination of the oligomerization state by 15N relaxation analysis
The structural analysis presented here is based on the assumption that the BRCT domain is
monomeric. This assumption is consistent with relaxation data (R1 and R2) measured at 11.7
T, which yielded an isotropic rotational correlation time of 10.0 ns [41,42]. This result is also
consistent with our previous analysis of relaxation data for the Pol µ BRCT domain, performed
at an identical temperature (10°C), which yielded a rotational correlation time of 10.5 ns
[14]. In addition, static and dynamic light scattering data for the Pol µ BRCT domain confirmed
its monomeric oligomerization state.
Analysis of structural dynamics
Based on the isotropic diffusion of the Pol λ BRCT domain, the relaxation data may be further
interpreted to analyze internal dynamics. Two regions of the protein exhibited decreased NOE
ratios, indicative of more rapid internal motion: the N-terminus and residues Gln76 and Gly77
(Suppl. Figure 2). Complete “model-free” analysis of 15N R1, R2 and NOE data [43] produced
no new insights beyond the increased dynamics of the aforementioned residues (data not
shown). Gln76 and Gly77 are located on the loop between β-strands 2 and 3. In the ensemble
of structures, these residues are poorly defined (Figure 2A, green).
CPMG experiments, designed to measure rates of conformational exchange on the millisecond
to microsecond time scale, showed more variation than the ps – ns motions derived from the
“model-free” analysis. Fourteen amide sites exhibit typical dispersion curves (Suppl. Figure
3A). These curves indicate conformational exchange, but as reviewed by Kempf, et al [44], it
is difficult to fit exact rates when the shapes are similar to exponential decay. The rest of the
measurable amide sites yielded dispersion curves closer to flat lines (Suppl. Figure 3B),
indicating no detectable conformational change.
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On the face of the protein that exhibits less sequence conservation (i.e. the regions containing
α-helix 2), the residues with dispersion curves clustered near the intersection of the two proline-
rich loops, P74AQGPG and P101QLPPGA (Figure 4A, Figure 6A, and Suppl. Figure 3).
Interestingly, residues Arg45, Thr81, and Gly106 adjacent to these loops show multiple peaks
in the 1H-15N HSQC spectra, indicative of slow exchange (Figure 1). In these cases, the 13C
shifts of the residues in the HNCACB experiment were similar enough that the extra peaks
could be confidently assigned to each residue (Figure 6A, colored yellow). The backbone atoms
of these three residues are in close proximity and are one or two residues displaced from the
residue beginning each β-strand. It is likely that these slow exchange conformers are related
to proline isomerization.
In contrast, on the opposite face of the β-sheet, there is a higher level of sequence conservation,
and decreased conformational exchange broadening. One exception to this involves a patch of
mostly hydrophobic surface-exposed residues including Leu117, Phe130, and Glu87 (Figure
6B, colored pink) that show conformational exchange in CPMG experiments (Suppl. Figure
3). In addition, Gly129 (Figure 6B, colored yellow) exhibits an extremely broad peak in
comparison to other glycine residues (Figure 1). The amide resonance of Ala113, which lies
in a congested region of the spectrum, is split into two slowly exchanging components. Since
there are no proline residues in the vicinity of Ala113, this heterogeneity is unlikely to
correspond to proline isomerism, but may relate to alternate conformations of some of the
nearby aromatic residues such as Trp114 or Phe140. Overlap of the Ala113 resonance with
other amide peaks (Figure 1, inset) limited the relaxation studies of this residue.
Discussion
With the solution structure of the Pol λ BRCT domain, we now have a complete portrait of the
human Family X BRCT domains. In general, the structural and electrostatic characteristics of
the exposed surface support the conclusion that they can serve as alternate polymerases by
docking with a common binding site in the NHEJ complex. Further, structural and mutation
data for the Pol µ and Pol λ BRCT domains demonstrate the importance of residues along and
near α-helix 1 in mediating the roles of these polymerases in NHEJ. Nevertheless, the fact that
each of the BRCT domains contains unique structural features indicates that they do not serve
as equivalent, interchangeable modules. Furthermore, based on the degree of sequence and
structural homology determined in the present study, the BRCT domain of Pol λ is more
dissimilar than the other two members of the Pol X family.
The work presented here further substantiates the proposed protein-protein interaction surface
linking the Family X BRCT domains to the NHEJ complex of Ku/XRCC4/Ligase IV [14].
According to the proposed hypothesis, the ‘shoulder’ of the Pol µ BRCT domain involved in
binding the NHEJ complex is formed by the C-terminal end of β-strand 1, the N-terminal half
of α-helix 1, and the loop connecting these two structural elements. The BRCT domains of Pol
µ/TdT each contain three conserved, surface-exposed residues: Arg43/Arg48, Phe46/Phe51
and Leu50/Leu55 that, when mutated to alanine, disrupt formation of the NHEJ complex at
the sites of DSBs [14]. The BRCT domain of Pol λ, contains an arginine residue (Arg57)
similarly positioned at the N-terminal end of α-helix 1, but with Leu60 substituting for Phe46
in Pol µ. The conservative substitution of Leu for Phe is likely to be sufficient to support binding
to the same receptor and, as demonstrated above, L60A reduces binding, although the effect
is considerably less dramatic than the effect of the F46A mutation in Pol µ. In contrast, the
third conserved leucine residue is nonconservatively replaced by Gln64 in Pol λ, which when
mutated to alanine, was shown to be unimportant for binding the NHEJ complex. Therefore,
comparing the effects of corresponding mutations at the homologous positions of Pol µ and
Pol λ on XRCC4-Ligase IV binding suggests a model characterized by a significant affinity
gradient along α-helix 1, so that the interaction near the N-terminus is relatively enhanced,
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becoming progressively weaker moving down the helix (Figure 7). One possible interpretation
is that the specific interaction surface created by the key residues in Pol λ may yield a greater
shape complementarity with the NHEJ complex. Another possible theory is that α-helix 1 may
tilt away from the interaction surface, perhaps as a consequence of stronger and/or additional
interactions with the preceding flexible loop. Structural elements exhibiting enhanced
flexibility such as the BRCT Loop 1 are thought to facilitate induced-fit recognition, and this
type of behavior has been noted in a variety of other systems, e. g. chemokines [45] and
fibronectins [46].
In general, it is not surprising that the BRCT domains of each polymerase should bind to the
same site, since the enzymes ultimately perform a similar polymerization function. However,
some differences should exist that select for a particular polymerase depending on the details
of the substrate structure. An alternative binding mode may have developed as a method to
make the more accurate Pol λ the preferred polymerase under certain conditions. A second
factor to be considered is the differing substrate specificities exhibited by Pol µ and Pol λ. Of
these two polymerases, Pol µ has the ability to bind and resolve DSBs where no
complementarity exists between the two ends [6,47]. However, Pol λ requires at least a single
complementary base pair at the site of the DSB [6]. A variation in the BRCT domain interaction
with other components of the NHEJ complex might cause alterations that could allow greater
access for the polymerase domain at the site of the DSB, dependent on the structure of the DSB
requiring repair. Additionally, the extended length of the Pro/Ser-rich linker connecting the
Pol λ BRCT and polymerase domains could influence such alterations. A final factor to
consider is the putative role of Pol λ in BER, which would presumably involve a different set
of interactions and a different docking site. This explanation is consistent with the more
significant structural differences noted above between the BRCT domain of Pol λ compared
with that of Pol µ and TdT.
With this contribution, there is structural information available for all of the Family X
polymerization domains, and for each of the three BRCT domains. In addition, the completion
of the Family X structural portrait, including the polymerase domains, was achieved through
the cooperative contributions of X-ray crystallography [15] and NMR spectroscopy [14]. By
means of this approach, we have discovered a means to elucidate the catalytic mechanism; the
intricacies of nucleotide incorporation fidelity; the structural contributions to selection of DNA
substrates; and the basis of interactions with other proteins which endow biological function.
Studies directed at determining the structure of the multi-component NHEJ complex are
currently in progress.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Annotated HSQC of [1H-15N]-Pol λ BRCT domain. Inset: Expanded view of degenerate peaks
surrounding Ala113.
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Ensemble and secondary structure of Pol λ BRCT domain. (A) The ensemble of structures
shows good convergence with the exception of a few loops. (B) The core parallel β-sheet
characteristic of BRCT domains is well determined. The lowest energy structure from the
ensemble was used to generate this image, using PyMOL [49]. The secondary structural
elements are shaded from blue to red; α-helices and β-strands are labeled numerically.
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Structural alignment of the BRCT domains of the Family X polymerases. (A). Superposition
of the BRCT domains from human Pol µ (PDB code 2DUN, maroon), TdT (PDB code 2COE,
green), and Pol λ (PDB code 2JW5, blue). α-helices (cylinders) and β-strands (directional
arrows) are labeled numerically. This figure was created using MolScript [50] and Raster3D
[51] (B). Structure-based primary sequence alignment. The positions of the conserved
secondary structural elements of the Pol λ BRCT domain are shown as follows: β-strands are
drawn as green boxes and α-helices are drawn as blue boxes. Structurally homologous residues
are in capital letters, while nonhomologous regions are shown in lower-case letters. Absolutely
conserved residues are indicated by asterisks below the alignment, and nearly conserved
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residues are dashed. The PPG motif is boxed in yellow. The conserved valine residue required
for protein stability is shown in green. Residues mutated for biochemical analysis of binding
to NHEJ protein partners are in magenta.
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Comparison of the structural differences seen in Family X BRCT domain loop regions.
Secondary structural elements of Pol λ BRCT are shown in the background in light gray. (A).
Superposition of the loop between β-strand 1 and α-helix 1 in Pol µ (PDB code 2DUN, maroon),
TdT (PDB code 2COE, green), and Pol λ (PDB code 2JW5, blue). (B). Superposition of the
loop between α-helix 2 and β-strand 4 in Pol µ (PDB code 2DUN, maroon), TdT (PDB code
2COE, green), and Pol λ (PDB code 2JW5, blue).
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NHEJ activity of Pol λ BRCT domain mutants. (A). Pol λ (PDB code 2JW5), blue)
superimposed with Pol µ (PDB code 2DUN, maroon). Residues in α-helix 1 crucial for
interaction with core NHEJ factors in Pol µ (R43, F46, and L50, light red) are shown with
sticks, relative to tested positions in Pol λ (R55, R57, L60 and Q64, light blue). Secondary
structural elements of Pol λ BRCT are shown in the background in light gray. (B). EMSA
analysis was performed in the presence of a 60 bp DNA duplex, Ku and the XRCC4-ligase IV
(X4-LIV) complex and various full-length Pol λ proteins. . The composition of each species
of distinct mobility is noted with cartoons at the left of the panel. C) Joining of a 300 bp substrate
with three nucleotide AGC 3’ overhangs was performed in the presence of Ku, XRCC4-Ligase
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IV, and various full-length Pol λ constructs as noted. S, substrate, P, joined concatemer
products.
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Two views of slow motions in Pol λ BRCT domain. Residues that demonstrated Rex from
CPMG experiments are colored magenta, and residues with multiple peaks in the 15N-1H
HSQC are colored yellow. Proline residues are colored cyan. (A). Numerous residues in the
vicinity of prolines that display either Rex or slow exchange cross-peaks. (B). A patch of
surface-exposed residues that are mostly hydrophobic, and also show either Rex or slow
exchange cross-peaks.
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Molecular surface of Pol λ and Pol µ BRCT domains, highlighting important residues for NHEJ
interactions. Pol λ (A) and Pol µ (B) are rendered, highlighting residues tested for NHEJ
activity. Residues with activity similar to wildtype are colored orange and residues showing
decreased binding and NHEJ activity are colored green.
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Medium range (i, i±2–4) 424
Long range (i, i>4) 635
Total 1916




Secondary Structure Backbone 0.68
Secondary Structure Heavy 1.49
Violations
NOE 2.5 +/− 1.1
RDC 0
Dihedral 0.67 +/− 0.65
RMS experimental
NOE 0.047 +/− 0.005
Dihedral 0.87 +/− 0.17
HBDA 0.022 +/0 0.004
RDC 0.1 Hz +/− 0.02
  (R-Factor) 0.1% +/− 0.05
RMS covalent geometry
Bonds 0.0049 +/− 0.00029
Angles 0.52 +/− 0.023
Impropers 0.43 +/− 0.028
Ramachandran Space(a)
Most Favored Region 69.1%
Additionally Allowed Region 19.8%
Generously Allowed Region 8.6%
Disallowed Region 2.5%
All data calculated with XPLOR-NIH [33], except for (a) calculated with PROCHECK [48].
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